
News|Articles|October 1, 2001
Dalteparin for enoxaparin interchange: Chart review shows promising clinical, economic outcomes
University Hospital and Medical Center (Tamarac)/University of Florida (Gainesville)-Dalteparin appears to be at least as clinically effective as enoxaparin for the prevention or treatment of the consequences of venous and arterial thromboembolic diseases, say clinicians from these two facilities.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FAQ: The uncertain future of enhanced ACA premium subsidies and what it means for U.S. healthcare
2
Weakened brain connections linked to cognitive deficits in schizophrenia
3
What UnitedHealth Group’s earnings call reveals about managed care trends
4
Could GLP-1s help with cognitive symptoms, pychosis of schizophrenia?
5



























